Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

October 11, 2021

[Clinical Characteristics and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Gene Rearrangement].

Zhongguo shi yan xue ye xue za zhi
Ning LuMeng Li
October 7, 2021

Adding venetoclax to fludarabine/busulfan RIC transplant for high risk MDS and AML is feasible, safe, and active.

Blood Advances
Jacqueline S GarciaJoseph H Antin
September 28, 2021

Leukemia cutis and other dermatological findings in pediatric patients with acute myeloid leukemia.

Boletín médico del Hospital Infantil de México
Juan A Godínez-ChaparroMirna E Toledo-Bahena
September 22, 2021

[Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
T M WuD P Wu
September 11, 2021
Open Access

Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patients.

Journal of Translational Medicine
Jizhang BaoWenwei Zhu
September 7, 2021

One Year Disease Free Survival In Acute Myeloid Leukemia Patients After Induction Remission.

Journal of Ayub Medical College, Abbottabad : JAMC
Mehwish Roshan ShaikhMaryum Nouman
September 2, 2021

Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.

Pediatric Blood & Cancer
Kelly D GetzRichard Aplenc
August 13, 2021

[Analysis of fusion gene expression in acute myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Q YanK Ru
August 12, 2021
Open Access

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML.

Frontiers in Oncology
Mikhail S ChesnokovAndrei L Gartel
August 10, 2021

GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.

International Journal of Laboratory Hematology
Fang FangHongwei Wang

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2021 Meta ULC. All rights reserved